Navigation Links
The Contract Biomanufacturing Market Outlook to 2017
Date:3/7/2013

NEW YORK, March 7, 2013 /PRNewswire/ --Reportlinker.com announces that a new market research report is available in its catalogue:

The Contract Biomanufacturing Market Outlook to 2017
http://www.reportlinker.com/p01118464/The-Contract-Biomanufacturing-Market-Outlook-to-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biopharmaceutical

Introduction

The volume demand for biologics active pharmaceutical ingredients (API) from 2011-2017 is set to show a 20% annual increase. Combined with a boost in biosimilars, the biologics contract manufacturing market is forecast to grow 9% per year over the same period.

Scope

• Develop a winning expansion and outsourcing strategy to grow your market share with forecasts through to 2017
• Assess the areas to target and use your findings to help increase profits with information on drivers and resistors of outsourced biomanufacturing
• Use the forecast for biologic and CMO market to adapt your strategy and ensure you're commercially successful
• With analysis on the 5 leading players you will understand what your competitors are doing and what actions you can take to stay competitive
The biological contract manufacturing organization (CMO) market will grow at a compound annual growth rate (CAGR) of 9.4% between 2011 and 2017. Mammalian contract manufacturing accounted for almost two thirds of the market in 2012, which was estimated at a size of $3bn.

Increasing API demand driven by biologics market growth and an increase in the number of late-stage clinical trials and approved biotech products will be the biggest drivers of the bio-CMO market.

Reasons to Buy

• What is the state of contract biomanufacturing in emerging regions?
• Who are the leading bio-CMOs and what are their strategies, strengths and weaknesses?
• What is the most attractive area of investment in the biologics market?

Table of Contents

Overview 4
Catalyst 4
–– Summary 4
Executive Summary 5
Market Overview 6
Definition 6
Segmentation 6
–– Categories of CMOs and services offered 7
References 9
Market Dynamics 10
Drivers 10
–– Growth of large molecule market 10
–– Cost savings 11
–– Risk reduction and risk sharing 11
–– Lead-time saving 11
–– Access to expertise and technology 12
–– Orphan drugs 12
–– Growth in emerging markets 13
–– Biosimilars 13
Resistors 14
–– Increasing yields and disposable technology 14
–– Overcapacity and pharma's increasing in-house capacity 14
–– Regulatory uncertainty over biosimilars 14
Market forecasts 15
–– Microbial and mammalian drug market 15
–– Microbial vs mammalian CMO market 15
–– Biosimilars 15
–– Biomanufacturing installed base 16
Contract biomanufacturing in emerging regions 17
References 17
Leading Players 19
Summary 19
Introduction 19
Boehringer Ingelheim 20
–– Overview and capabilities 20
–– Partnerships, deals, and expansion plans 20
–– SWOT analysis 21
Lonza 21
–– Overview and capabilities 21
–– Partnerships, deals, and expansion plans 22
–– SWOT analysis 22
Sandoz 23
–– Overview and capabilities 23
–– Partnerships, deals, and expansion plans 23
–– SWOT analysis 23
Fujifilm Diosynth Biotechnologies 24
–– Overview and capabilities 24
–– Partnerships, deals, and expansion plans 24
–– SWOT analysis 24
DSM 25
–– Overview and capabilities 25
–– Partnerships, deals, and expansion plans 25
–– SWOT analysis 26
References 26
Appendix 29
Methodology 29
–– Pharmaceutical market 29
–– Bio-CMO market 29
References 29
Table 1: Categories of CMOs and services offered 7
Figure 1: Biopharma value chain 7
Figure 2: Small vs large molecule pharma market ($bn), 2008–17 10
Figure 3: Number of orphan drug NMEs historically and
forecasted average in the US, 2005–16 12
Figure 4: Biopharmaceutical drug market by major product
group ($bn), 2011–17 15
Figure 5: Mammalian and microbial API CMO market ($bn),
2010–17 16
Figure 6: Comparison of leading bio-CMOs by capability 19

Companies Mentioned

First Aviation Services Inc., Hutchison 3G UK Limited

To order this report:
Biopharmaceutical Industry: The Contract Biomanufacturing Market Outlook to 2017

_________________________
Contact Clare: clare@reportlinker.com
US:(339) 368 6001
Intl:+1 339 368 6001


'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Watchdog Organization Releases Toolkit to Help Employers Navigate Pharmacy Benefits Contracts
2. Groupe Athena, Inc. Enters Multi Year Contractual Relationship With Major Bangladesh Pharmaceutical Manufacturer
3. Medical Device Contract Manufacturing: World Market Outlook 2013-2023
4. Romark Laboratories Awarded Contract For Late-Stage Development Of New Influenza Drug
5. CliniComp Announces Contract Wins With Daughters of Charity Health System
6. Odyssey Thera, Inc. Announces New Equity Financing and Initiation of Research Contract with Merck
7. Comprehensive Care Corporation Announces New Medicare Contract with Humana Health Plan of California, Inc.
8. Contract Manufacturing Organizations to 2018 - Cost Advantages and Improving Quality Standards Build Confidence and Encourage Foreign Investment in Asian CMOs
9. Contract Research Organisations offer Promise of Innovative, Safe and Effective Drug Development, Says Frost & Sullivan
10. Global BioClinical Awarded Cancer Genome Atlas (TCGA) Contract
11. National Institute of Health Awards Contract to Support Use of iBios Proprietary Technology for Improved Anthrax Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)...  This month,s issue of the Journal of ... in-depth look at various causes and consequences associated with rising health ... which has generated significant public outrage and calls for ... E. Happe , PharmD, MPH. --> JMCP ... --> In 2014 prescription drug spending in ...
(Date:2/12/2016)... 2016  Innophos Holdings, Inc. (NASDAQ: IPHS ), a ... announced that it will host a live conference call on ... its fourth quarter and full year 2015 results. ... detailing fourth quarter and full year results will be issued ... --> --> The conference call ...
(Date:2/12/2016)... Mass. , Feb. 12, 2016   HeartWare ... a conference call and webcast to discuss its financial ... 31, 2015, on Thursday, February 25, 2016 at 8:00 ... results prior to the conference call and webcast.  On ... company,s financial results, highlights from the fourth quarter and ...
Breaking Medicine Technology:
(Date:2/13/2016)... (PRWEB) , ... February 13, 2016 , ... Valentine’s Day ... a date for the big day. A great outfit, flawless hair, and a sparkling ... might as well resign themselves to a night at home with Rover. (Actually, man’s ...
(Date:2/13/2016)... ... 13, 2016 , ... Many individuals looking to lead a healthy lifestyle have ... IsoPasta by Isolator Fitness has delved into this niche allowing those giving up ... repercussions. IsoPasta has 30 grams of protein and only 7 grams of carbohydrates ...
(Date:2/13/2016)... ... 13, 2016 , ... The producers of Enterprises TV are pleased ... increasingly modern world of instantaneous consumption proves very convenient for businesses. With new technologies ... and coal, which pollutes our air, water, and soil. It can also threaten the ...
(Date:2/13/2016)... ... February 13, 2016 , ... Christie Medical ... in-kind gift of a VeinViewer® Vision vein finder for the nursing ... start an IV and draw blood, combining technology with traditional technique. , “VeinViewer ...
(Date:2/13/2016)... ... ... In the early or “honeymoon” stage of a relationship, couples strive to put ... to be romantic, and may exaggerate a strength or two in an effort to ... , A recent study from Queendom.com , however, suggests that new couples who ...
Breaking Medicine News(10 mins):